Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
04/2012
04/03/2012US8148347 Inhibition of interaction of PSD93 and PSDS95 with nNOS and NMDA receptors
04/03/2012US8148343 Tumor suppressor factor
04/03/2012US8148332 Method for treating a rheumatic disease using a soluble TLA4 molecule
04/03/2012US8148331 Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof
04/03/2012US8148324 Chemoenzymatic methods for the synthesis of statins and statin intermediates
04/03/2012US8148320 Peptide inhibitors of ABL kinases
04/03/2012US8148141 Solid support comprising fixed amino acid sequences with cysteine terminals for use as recognition tool for detection of preferential polypeptides in solution; high throughput assay
04/03/2012US8148125 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
04/03/2012US8148109 Interferon-like proteins and uses thereof
04/03/2012US8148104 Use in treatment of paper pulp or animal feeds; enzyme is active over a wide range of temperature and of basic and acid pH
04/03/2012US8148103 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
04/03/2012US8148098 Methods of cleaving DNA with rationally-designed meganucleases
04/03/2012US8148091 Detection of chronic kidney disease patients or coronary artery disease using bone morphogenic protein-4
04/03/2012US8148082 Phenylthiocarbamide (PTC) taste receptor
04/03/2012US8148080 Gene and protein relating to hepatocellular carcinoma and methods of use thereof
04/03/2012US8147856 AXMI-031, AXMI-039, AXMI-040 and AXMI-049, a family of novel delta-endotoxin genes and methods for their use
04/03/2012US8147849 Protective antigens for group B Streptococcus hypervirulent strains
04/03/2012US8147844 Mpl ligand (thrombopoietin), nucleic acids encoding such, and methods of treatment using mpl ligand
04/03/2012US8147843 CD95L or trail fusion proteins
04/03/2012US8147841 Clostridium toxin, and process for the preparation of immunogenic composition
04/03/2012US8147840 Human immunodeficiency virus (HIV) immunization strategies employing conformationally-stabilized, surface-occluded peptides comprising a gp41 2F5 epitope in association with lipid
04/03/2012US8147839 Fusion proteins of HIV regulatory/accessory proteins
04/03/2012US8147828 Methods and compositions for modulation of blood-neural barrier
04/03/2012US8147823 Method of treating or retarding the development of blindness
04/03/2012US8147822 Oncolytic virus
04/03/2012US8147819 Peptides for active anti-cytokine immunization
04/03/2012US8147817 IL-33 in the treatment and diagnosis of diseases and disorders
04/03/2012CA2586153C Mutant porcine reproductive and respiratory syndrome virus
04/03/2012CA2493329C Releasable polymeric conjugates based on aliphatic biodegradable linkers
04/03/2012CA2481936C Canola protein isolate compositions
04/03/2012CA2473263C Novel calpastatin (cast) alleles
04/03/2012CA2465377C Method for producing and identifying soluble protein domains
04/03/2012CA2453115C Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
04/03/2012CA2435466C Use of il-18 inhibitors for the treatment and/or prevention of heart disease
04/03/2012CA2433194C Comparative ligand mapping from mhc positive cells
04/03/2012CA2424789C Multiple inducible gene regulation system
04/03/2012CA2379220C Structural protein of adeno-associated virus with modified antigenicity, its production and its use
04/03/2012CA2374675C Modified factor viii
04/03/2012CA2347411C Virus-like particles for the induction of autoantibodies
04/03/2012CA2315677C Maize h3c4 promoter associated with first rice actin intron, chimeric gene containing it and transformed plant
04/03/2012CA2304211C Gram negative coccoid bacterium
04/03/2012CA2304105C Control pod dehiscence or shatter
04/03/2012CA2304103C Control of plant abscission and pod dehiscence or shatter
04/03/2012CA2302545C In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps)
04/03/2012CA2226287C Novel secretion factors for gram-positive microorganisms, genes encoding them and methods of using it
04/03/2012CA2198461C Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (prrsv), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a prrsv and a method of detecting a prrsv
03/2012
03/29/2012WO2012040421A1 Formulations for bovine granulocyte colony stimulating factor and variants thereof
03/29/2012WO2012040406A2 Influenza treatment and/or characterization; human-adapted ha polypeptides; vaccines
03/29/2012WO2012040364A1 Calcitonin products and therapies for treating inflammatory or degenerative diseases
03/29/2012WO2012040323A2 Multimeric il-15 soluble fusion molecules and methods of making and using same
03/29/2012WO2012040012A1 Anti-ssx-2 t cell receptors and related materials and methods of use
03/29/2012WO2012039607A1 Methods to produce bunyavirus replicon particles
03/29/2012WO2012039559A2 Tofi variant proteins and method for producing the same
03/29/2012WO2012039469A1 Method for screening binding inhibitor of rage and age
03/29/2012WO2012038957A1 Ktpaf50 (prt3) for treating diseases of the pancreas
03/29/2012WO2012038950A1 Activatable toxin complexes comprising a cleavable inhibitory peptide
03/29/2012WO2012038929A1 Cosmetic use of dermicidin, and analogues or fragments thereof
03/29/2012WO2012038918A1 Therapeutic product inhibitor of the cell proliferation and biological applications thereof
03/29/2012WO2012038822A1 Improved process for production of recombinant human growth hormone
03/29/2012WO2012038717A1 Transgenic plants
03/29/2012WO2012038607A1 Oncolytic adenoviral vectors and methods and uses related thereto
03/29/2012WO2012038540A2 Peptides
03/29/2012WO2012038530A1 Plants resistant to fungal pathogens and methods for production thereof
03/29/2012WO2012038528A1 Plants resistant to fungal pathogens and methods for production thereof
03/29/2012WO2012038454A1 Bvdv vaccine
03/29/2012WO2012038410A1 Process for production of fibrinogen
03/29/2012WO2012038367A1 Therapeutic vaccination against active tuberculosis
03/29/2012WO2012038055A1 Antigen-specific t cell receptors and t cell epitopes
03/29/2012WO2012037687A1 Therapeutic polypeptides and uses thereof
03/29/2012WO2012037616A1 Interferon-nu
03/29/2012WO2012037603A1 Biomarkers associated with pre-diabetes, diabetes and diabetes related conditions
03/29/2012WO2012013960A3 Tunicamycin gene cluster
03/29/2012WO2012010872A3 Plant cytochrome p450
03/29/2012WO2012006732A8 Affinity purification of rna under native conditions based on the lambda boxb/n peptide interaction
03/29/2012WO2012004664A3 Analogs of sodium channel peptide toxin
03/29/2012WO2012004384A3 Polypeptides
03/29/2012WO2011159777A3 Chimeric cytokine of il-7 and alpha-chain of hgf and methods of use
03/29/2012WO2011159741A3 Tetranor-pgem/pgam specific immunogens, antibodies, tracers, assay kits and methods for making same
03/29/2012WO2011153522A3 Compounds and methods for fret based measurement of enzyme activity
03/29/2012WO2011150181A3 Compositions and methods for treating or inhibiting infection by francisella tularensis
03/29/2012WO2011140267A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
03/29/2012WO2011140132A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases
03/29/2012WO2011130666A9 Plants with altered cell wall biosynthesis and methods of use
03/29/2012WO2011112935A3 Antibody fusion proteins with disrupted heparin-binding activity
03/29/2012WO2011084711A3 Hair growth methods using fgfr3 extracellular domains
03/29/2012WO2011063990A3 Spider silk particles for controlled and sustained delivery of compounds
03/29/2012WO2010142981A3 Composition and uses thereof
03/29/2012US20120079628 Compositions and methods for modulation of plant cell division
03/29/2012US20120079623 Yield Enhancement in Plants by Modulation of a ZM-ZFP1 Protein
03/29/2012US20120079622 Yield Enhancement in Plants by Modulation of a ZM-LOBDP1 Protein
03/29/2012US20120079616 Npc1l1 (npc3) and methods of use thereof
03/29/2012US20120079614 Cd109 polypeptides and uses thereof for the treatment of skin cells
03/29/2012US20120079613 Homeobox Transcription Factor BSX and Uses Thereof for Treating Diseases, in Particular Obesity
03/29/2012US20120077965 Non-aqueous synthesis of polysaccharide-protein conjugates for vaccines
03/29/2012US20120077960 Fluorobodies: intrinsically fluorescent binding ligands
03/29/2012US20120077948 Methods
03/29/2012US20120077757 Methods for Affecting Homology-Directed DNA Double Stranded Break Repair
03/29/2012US20120077754 Copolymer-1 improvements in compositions of copolymers
03/29/2012US20120077751 Methods for modulating neuronal responses
03/29/2012US20120077740 Methods for making Apo-2 Ligand using divalent metal ions
1 ... 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 ... 2916